Cover Image

Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa

In South Africa, the prevalence of human papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is among the highest in the world. This study evaluates the cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination for 9- to 14-year-old girls from...

Full description

Saved in:
Bibliographic Details
Main Authors: Michaeli, Daniel (Author) , Stoycheva, Sophia (Author) , Marcus, Simon Mashudu (Author) , Zhang, Wenjia (Author) , Michaeli, Julia (Author) , Michaeli, Christoph T. (Author)
Format: Article (Journal)
Language:English
Published: 16 March 2022
In: Clinical drug investigation
Year: 2022, Volume: 42, Issue: 4, Pages: 333-343
ISSN:1179-1918
DOI:10.1007/s40261-022-01138-6
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s40261-022-01138-6
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s40261-022-01138-6
Get full text
Author Notes:Daniel Tobias Michaeli, Sophia Stoycheva, Simon Mashudu Marcus, Wenjia Zhang, Julia Caroline Michaeli, Thomas Michaeli
Description
Summary:In South Africa, the prevalence of human papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is among the highest in the world. This study evaluates the cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination for 9- to 14-year-old girls from the South African healthcare system perspective.
Item Description:Gesehen am 19.03.2024
Physical Description:Online Resource
ISSN:1179-1918
DOI:10.1007/s40261-022-01138-6

Similar Items